BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28646687)

  • 1. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints.
    Teipel SJ; Cavedo E; Weschke S; Grothe MJ; Rojkova K; Fontaine G; Dauphinot L; Gonzalez-Escamilla G; Potier MC; Bertin H; Habert MO; Dubois B; Hampel H;
    Neurobiol Aging; 2017 Sep; 57():143-152. PubMed ID: 28646687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Cavedo E; Chiesa PA; Houot M; Ferretti MT; Grothe MJ; Teipel SJ; Lista S; Habert MO; Potier MC; Dubois B; Hampel H; ;
    Alzheimers Dement; 2018 Sep; 14(9):1204-1215. PubMed ID: 30201102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.
    Oh H; Habeck C; Madison C; Jagust W
    Hum Brain Mapp; 2014 Jan; 35(1):297-308. PubMed ID: 22965806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.
    Harrison TM; Maass A; Baker SL; Jagust WJ
    Neurobiol Aging; 2018 Jul; 67():162-170. PubMed ID: 29665578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project.
    McCluskey GE; Yates P; Villemagne VL; Rowe C; Szoeke CEI
    Brain Imaging Behav; 2018 Feb; 12(1):78-86. PubMed ID: 28108945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Basal Forebrain Resting-State Functional Connectivity and Brain Amyloid-β Deposition in Cognitively Intact Older Adults with Subjective Memory Complaints.
    Chiesa PA; Cavedo E; Grothe MJ; Houot M; Teipel SJ; Potier MC; Habert MO; Lista S; Dubois B; Hampel H;
    Radiology; 2019 Jan; 290(1):167-176. PubMed ID: 30351255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints.
    Teipel S; Bakardjian H; Gonzalez-Escamilla G; Cavedo E; Weschke S; Dyrba M; Grothe MJ; Potier MC; Habert MO; Dubois B; Hampel H;
    Neuroimage Clin; 2018; 17():435-443. PubMed ID: 29159056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals.
    Jacobs HIL; Hedden T; Schultz AP; Sepulcre J; Perea RD; Amariglio RE; Papp KV; Rentz DM; Sperling RA; Johnson KA
    Nat Neurosci; 2018 Mar; 21(3):424-431. PubMed ID: 29403032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.
    Caldwell JZK; Berg JL; Cummings JL; Banks SJ;
    Alzheimers Res Ther; 2017 Sep; 9(1):72. PubMed ID: 28899422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.
    Cole JH; Annus T; Wilson LR; Remtulla R; Hong YT; Fryer TD; Acosta-Cabronero J; Cardenas-Blanco A; Smith R; Menon DK; Zaman SH; Nestor PJ; Holland AJ
    Neurobiol Aging; 2017 Aug; 56():41-49. PubMed ID: 28482213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
    Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
    Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
    Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.